EMT or EMT-promoting transcription factors, where to focus the light?

Frontiers in Oncology

Volumn 4, Issue NOV, 2014, Pages

  Ansieau, Stéphane ^a,b,c   Collin, Guillaume ^a,b,c   Hill, Louise ^a,b,c  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b LabEx DEVweCAN   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN KINASE B BETA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; EPITHELIAL MESENCHYMAL TRANSITION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 84949114944     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00353     Document Type: Article

References (44)

1. Alba-Castellon, L., Batlle, R., Franci, C., Fernandez-Acenero, M.J., Mazzolini, R., Pena, R., Loubat, J., Alameda, F., Rodriguez, R., Curto, J., Albanell, J., Munoz, A., Bonilla, F., Ignacio, C.J., Rojo, F., and Garcia de, H.A. (2014). Snail1 expression is required for sarcomagenesis. Neoplasia. 16, 413-421.
2. Ansieau, S., Bastid, J., Doreau, A., Morel, A.P., Bouchet, B.P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S., Maestro, R., Voeltzel, T., Selmi, A., Valsesia-Wittmann, S., Caron de, F.C., and Puisieux, A. (2008). Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14, 79-89.
3. Ansieau, S., Morel, A.P., Hinkal, G., Bastid, J., and Puisieux, A. (2010). TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29, 3173-3184.
4. Batlle, R., Alba-Castellon, L., Loubat-Casanovas, J., Armenteros, E., Franci, C., Stanisavljevic, J., Banderas, R., Martin-Caballero, J., Bonilla, F., Baulida, J., Casal, J.I., Gridley, T., and Garcia de, H.A. (2013). Snail1 controls TGF-beta responsiveness and differentiation of mesenchymal stem cells. Oncogene 32, 3381-3389.
5. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., and Kirchner, T. (2005). Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749.
6. Burns, T.F., Dobromilskaya, I., Murphy, S.C., Gajula, R.P., Thiyagarajan, S., Chatley, S.N., Aziz, K., Cho, Y.J., Tran, P.T., and Rudin, C.M. (2013). Inhibition of TWIST1 leads to activation of oncogeneinduced senescence in oncogene-driven non-small cell lung cancer. Mol. Cancer Res. 11, 329-338.
7. Caramel, J., Papadogeorgakis, E., Hill, L., Browne, G.J., Richard, G., Wierinckx, A., Saldanha, G., Osborne, J., Hutchinson, P., Tse, G., Lachuer, J., Puisieux, A., Pringle, J.H., Ansieau, S., and Tulchinsky, E. (2013). A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24, 466-480.
8. Dave, N., Guaita-Esteruelas, S., Gutarra, S., Frias, A., Beltran, M., Peiro, S., and de Herreros, A.G. (2011). Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 286, 12024-12032.
9. De Craene, B. and Berx, G. (2013). Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97-110.
10. Denecker, G., Vandamme, N., Akay, O., Koludrovic, D., Taminau, J., Lemeire, K., Gheldof, A., De, C.B., Van, G.M., Brochez, L., Udupi, G.M., Rafferty, M., Balint, B., Gallagher, W.M., Ghanem, G., Huylebroeck, D., Haigh, J., van den Oord, J., Larue, L., Davidson, I., Marine, J.C., and Berx, G. (2014). Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression. Cell Death. Differ. 21, 1250-1261.
11. Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T.W., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., Lorkiewicz, P., St, C.D., Hung, M.C., Evers, B.M., and Zhou, B.P. (2013). Loss of FBP1 by Snailmediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23, 316-331.
12. Escriva, M., Peiro, S., Herranz, N., Villagrasa, P., Dave, N., Montserrat-Sentis, B., Murray, S.A., Franci, C., Gridley, T., Virtanen, I., and Garcia de, H.A. (2008). Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Mol. Cell Biol. 28, 1528-1540.
13. Franci, C., Takkunen, M., Dave, N., Alameda, F., Gomez, S., Rodriguez, R., Escriva, M., Montserrat-Sentis, B., Baro, T., Garrido, M., Bonilla, F., Virtanen, I., and Garcia de, H.A. (2006). Expression of Snail protein in tumor-stroma interface. Oncogene 25, 5134-5144.
14. Guo, W., Keckesova, Z., Donaher, J.L., Shibue, T., Tischler, V., Reinhardt, F., Itzkovitz, S., Noske, A., Zurrer-Hardi, U., Bell, G., Tam, W.L., Mani, S.A., van, O.A., and Weinberg, R.A. (2012). Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015-1028.
15. Hoek, K.S. and Goding, C.R. (2010). Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746-759.
16. Lee, K.E. and Bar-Sagi, D. (2010). Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell 18, 448-458.
17. Liu, Y., El-Naggar, S., Darling, D.S., Higashi, Y., and Dean, D.C. (2008). Zeb1 links epithelialmesenchymal transition and cellular senescence. Development 135, 579-588.
18. Liu, Y., Sanchez-Tillo, E., Lu, X., Huang, L., Clem, B., Telang, S., Jenson, A.B., Cuatrecasas, M., Chesney, J., Postigo, A., and Dean, D.C. (2013). Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression. J. Biol. Chem. 288, 11572-11580.
19. Maestro, R., Dei Tos, A.P., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., Doglioni, C., Beach, D.H., and Hannon, G.J. (1999). Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13, 2207-2217.
20. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., Campbell, L.L., Polyak, K., Brisken, C., Yang, J., and Weinberg, R.A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715.
21. Morel, A.P., Hinkal, G.W., Thomas, C., Fauvet, F., Courtois-Cox, S., Wierinckx, A., Devouassoux-Shisheboran, M., Treilleux, I., Tissier, A., Gras, B., Pourchet, J., Puisieux, I., Browne, G.J., Spicer, D.B., Lachuer, J., Ansieau, S., and Puisieux, A. (2012). EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS. Genet. 8, e1002723.
22. Morel, A.P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S., and Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS. One. 3, e2888.
23. Ocana, O.H., Corcoles, R., Fabra, A., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., and Nieto, M.A. (2012). Metastatic colonization requires the repression of the epithelialmesenchymal transition inducer Prrx1. Cancer Cell 22, 709-724.
24. Ohashi, S., Natsuizaka, M., Wong, G.S., Michaylira, C.Z., Grugan, K.D., Stairs, D.B., Kalabis, J., Vega, M.E., Kalman, R.A., Nakagawa, M., Klein-Szanto, A.J., Herlyn, M., Diehl, J.A., Rustgi, A.K., and Nakagawa, H. (2010). Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res. 70, 4174-4184.
25. Piccinin, S., Tonin, E., Sessa, S., Demontis, S., Rossi, S., Pecciarini, L., Zanatta, L., Pivetta, F., Grizzo, A., Sonego, M., Rosano, C., Dei Tos, A.P., Doglioni, C., and Maestro, R. (2012). A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. Cancer Cell 22, 404-415.
26. Prat, A. and Perou, C.M. (2011). Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 5, 5-23.
27. Rodriguez, R., Rubio, R., and Menendez, P. (2012). Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res. 22, 62-77.
28. Sayan, A.E., Griffiths, T.R., Pal, R., Browne, G.J., Ruddick, A., Yagci, T., Edwards, R., Mayer, N.J., Qazi, H., Goyal, S., Fernandez, S., Straatman, K., Jones, G.D., Bowman, K.J., Colquhoun, A., Mellon, J.K., Kriajevska, M., and Tulchinsky, E. (2009). SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc. Natl. Acad. Sci. U. S. A 106, 14884-14889.
29. Scaffidi, P. and Misteli, T. (2011). In vitro generation of human cells with cancer stem cell properties. Nat. Cell Biol. 13, 1051-1061.
30. Schieber, M.S. and Chandel, N.S. (2013). ROS links glucose metabolism to breast cancer stem cell and EMT phenotype. Cancer Cell 23, 265-267.
31. Singh, A., Greninger, P., Rhodes, D., Koopman, L., Violette, S., Bardeesy, N., and Settleman, J. (2009). A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 15, 489-500.
32. Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., and Brabletz, T. (2006). A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131, 830-840.
33. Thiery, J.P., Acloque, H., Huang, R.Y., and Nieto, M.A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
34. Tran, D.D., Corsa, C.A., Biswas, H., Aft, R.L., and Longmore, G.D. (2011). Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol. Cancer Res. 9, 1644-1657.
35. Tran, P.T., Shroff, E.H., Burns, T.F., Thiyagarajan, S., Das, S.T., Zabuawala, T., Chen, J., Cho, Y.J., Luong, R., Tamayo, P., Salih, T., Aziz, K., Adam, S.J., Vicent, S., Nielsen, C.H., Withofs, N., Sweet-Cordero, A., Gambhir, S.S., Rudin, C.M., and Felsher, D.W. (2012). Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS. Genet. 8, e1002650.
36. Tsai, J.H., Donaher, J.L., Murphy, D.A., Chau, S., and Yang, J. (2012). Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725-736.
37. Tulchinsky, E., Pringle, J.H., Caramel, J., and Ansieau, S. (2014). Plasticity of melanoma and EMT-TF reprogramming. Oncotarget. 5, 1-2.
38. Valsesia-Wittmann, S., Magdeleine, M., Dupasquier, S., Garin, E., Jallas, A.C., Combaret, V., Krause, A., Leissner, P., and Puisieux, A. (2004). Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6, 625-630.
39. Vega, S., Morales, A.V., Ocana, O.H., Valdes, F., Fabregat, I., and Nieto, M.A. (2004). Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 18, 1131-1143.
40. Wellner, U., Schubert, J., Burk, U.C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., zur, H.A., Brunton, V.G., Morton, J., Sansom, O., Schuler, J., Stemmler, M.P., Herzberger, C., Hopt, U., Keck, T., Brabletz, S., and Brabletz, T. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11, 1487-1495.
41. Wu, W.S., Heinrichs, S., Xu, D., Garrison, S.P., Zambetti, G.P., Adams, J.M., and Look, A.T. (2005). Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123, 641-653.
42. Wu, Y., Deng, J., Rychahou, P.G., Qiu, S., Evers, B.M., and Zhou, B.P. (2009). Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416-428.
43. Yang, J. and Weinberg, R.A. (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829.
44. Zhang, P., Wei, Y., Wang, L., Debeb, B.G., Yuan, Y., Zhang, J., Yuan, J., Wang, M., Chen, D., Sun, Y., Woodward, W.A., Liu, Y., Dean, D.C., Liang, H., Hu, Y., Ang, K.K., Hung, M.C., Chen, J., and Ma, L. (2014). ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. Cell Biol. 16, 864-875.